| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -8,819 | 100% | $0.8900 | -$7,849 |
| Net | -1 | -8,819 | -100% | -$7,849 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Longitude Capital Partners III, LLC | 10%+ Owner | $14,902,533 | 19 Apr 2022 | ||
| Pivotal bioVenture Partners Fund I, L.P. | Director | $5,611,115 | 01 Aug 2023 | ||
| Henric Bjarke | Svp, Coo | $376,424 | 15 Dec 2022 | ||
| Matthew Winton | Coo | $184,675 | 01 Jul 2025 | ||
| Sanjay Subramanian | SVP, CFO & Head of BD | $171,325 | 01 Jul 2025 | ||
| Douglas A. Treco | CEO & Chairman, Director | $38,500 | -$7,849 | -17% | 01 Jul 2025 |
| Robert Lorne Hopfner | Director | $0 | 01 Jul 2025 | ||
| Axel Bolte | Director | $0 | 01 Jul 2025 | ||
| Inozyme Pharma, Inc. | Director | 23 Jun 2021 | |||
| Edward T. Mathers | Director | 18 Jun 2024 | |||
| Stephen J. DiPalma | Interim CFO | 17 May 2021 | |||
| Lynne Sullivan | Director | 01 Jul 2025 | |||
| Sarah Bhagat | Director | 18 Jun 2024 | |||
| Erik Harris | Director | 03 Oct 2024 | |||
| REINALDO M. DIAZ | Director | 18 Jun 2024 | |||
| Martin Edwards | Director | 18 Jun 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|